Samit Hirawat
Chief Tech/Sci/R&D Officer en BRISTOL-MYERS SQUIBB COMPANY .
Fortuna: 3 M $ al 31/03/2024
Perfil
Samit Hirawat is currently the Chief Medical Officer & EVP-Drug Development at Bristol Myers Squibb Co. Prior to this, he was the Head- Global Oncology Development at Novartis AG from 2017 to 2019.
He completed his undergraduate degree at SMS Medical College & Hospital.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 14/03/2024 | 60 279 ( 0.00% ) | 3 M $ | 31/03/2024 |
Cargos activos de Samit Hirawat
| Empresas | Cargo | Inicio |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | 01/01/2019 |
Antiguos cargos conocidos de Samit Hirawat.
| Empresas | Cargo | Fin |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01/06/2019 |
Formación de Samit Hirawat.
| SMS Medical College & Hospital | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| NOVARTIS AG | Health Technology |
- Bolsa de valores
- Insiders
- Samit Hirawat
